The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...

Skip More from 5 Live... The 5 Live at 30 Yearbook How 5 Live reported on some of the biggest news and sport stories of the past 30 years. Eleanor Oldroyd: 30 years of "my radio family" Eleanor ...

The Gadgets 360 Best Tablets page shows the top-rated tablets reviewed by us in the recent past. The tablets were launched less than 2 years ago, and have received a rating of 8 or above. When you ...